× Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our privacy policy



meta|IO

Evidence base on efficacy and safety of
Immuno-Oncology drugs

Global living systematic review and meta-analysis of RCTs

Pathology  

Latest studies

ASCENT (patients without brain metastases), 2021

breast cancer (BC)

sacituzumab govitecan

IMpassion-131 (PD-L1 > 1%), 2020

breast cancer (BC)

atezolizumab plus SoC

ASCENT (all population), 2021

breast cancer (BC)

sacituzumab govitecan

JAVELIN Gastric 100 (PDL1>1%), 2020

gastric or gastroesophageal junction cancer (GC)

avelumab alone

289
treatments 		  204
studies 		  853
references
This project is supported by H2020 Qualitop, an EU-funded project, Hospices Civils de Lyon and CNRS UMR5558 LBBE.
     

- About us - Contact us - Method - RSS Made with in Lyon - Credits - Privacy policy - Licence Creative Commons